Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflora incarnata tablets for cyclic breast pain in women
IRCT20100524004015N3Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 3 trial of passiflora incarnata in mastalgia, sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Change in severity of cyclic breast pain and Change in quality/characteristics of cyclic breast pain. Started Oct 2025; status: completed.
02
Drugs
passiflora incarnata
03
Conditions
mastalgia
Beyond the preview
Go deeper on IRCT20100524004015N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100524004015N3.